Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 EX-1.1
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.5 EX-3.5
- 3.6 EX-3.6
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 5.1 EX-5.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 14.1 EX-14.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- EX-FILING FEES Ex-filing Fees
Associated filings
- 31 May 24 424B4 Prospectus supplement with pricing info
- 31 May 24 424B3 Prospectus supplement
- 15 May 24 424B4 Prospectus supplement with pricing info
- 15 May 24 424B3 Prospectus supplement
- 14 May 24 EFFECT Notice of effectiveness
- 9 May 24 S-1/A IPO registration (amended)
- 9 Apr 24 S-1/A IPO registration (amended)
- 12 Mar 24 S-1/A IPO registration (amended)
- 7 Dec 23 S-1/A IPO registration (amended)
- 27 Nov 23 S-1/A IPO registration (amended)
- 20 Nov 23 S-1/A IPO registration (amended)
-
6 Nov 23 S-1/A IPO registration (amended)
- 26 Oct 23 S-1/A IPO registration (amended)
- 11 Oct 23 S-1/A IPO registration (amended)
- 20 Sep 23 S-1 IPO registration
KDLY similar filings
Filing view
External links
EXHIBIT 99.3
CONSENT OF DIRECTOR NOMINEE
In connection with the filing by Kindly MD, Inc. (the “Company”) of a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents, as required by Rule 438 under the Securities Act, to being named in the Registration Statement as a Director Nominee.
November 6, 2023
By: | /s/ Gary Seelhorst | |
Name: | Gary Seelhorst |